Combined therapy of interferon plus ribavirin promotes multiple adaptive solutions in hepatitis C virus
- 23 February 2009
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 81 (4) , 650-656
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Genetic Variability of Hepatitis C Virus before and after Combined Therapy of Interferon plus RibavirinPLOS ONE, 2008
- Refined analysis of genetic variability parameters in hepatitis C virus and the ability to predict antiviral treatment responseJournal of Viral Hepatitis, 2008
- Genetic variability in hepatitis C virus and its role in antiviral treatment responseJournal of Viral Hepatitis, 2007
- Analysis of Ribavirin Mutagenicity in Human Hepatitis C Virus InfectionJournal of Virology, 2007
- American Gastroenterological Association Technical Review on the Management of Hepatitis CGastroenterology, 2006
- Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus InfectionJournal of Virology, 2005
- Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapyHepatology, 2003
- Hepatitis C virus E2 and NS5A region variability during sequential treatment with two interferon-? preparationsJournal of Medical Virology, 2003
- Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.Journal of General Virology, 1998
- Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.Journal of Clinical Investigation, 1995